Nuplazid (pimavanserin) - Acadia Pharma
Nuplazid: "Up 23% year-over-year; highest ever quarterly sales" (Acadia) - May 8, 2025 - Q1 2025 Results 
Commercial CNS Disorders • Parkinson's Disease
https://edge.media-server.com/mmc/p/wgxjjsvd/
 
May 8, 2025
 
 
ad8c9adb-ab4c-4b3f-8620-d3508a74f960.png